208
Participants
Start Date
April 30, 2015
Primary Completion Date
November 30, 2017
Study Completion Date
November 30, 2017
Telminuvo®Tab. 40/2.5mg
per oral for 8weeks after 2\~4weeks run-in period with Telmitrend®Tab. 40mg
RECRUITING
Korean University Guro Hospital, Seoul
RECRUITING
Myongji Hospital, Goyang
RECRUITING
Inje University Ilsan Paik Hospital, Goyang-si
RECRUITING
Bundang Jesaeng Hospital, Seongnam-si
RECRUITING
Daegu Catholic University Medical Center, Dae-gu
RECRUITING
Keimyung University Dongsan Medical Center, Daegu
RECRUITING
Yeungnam University Medical Center, Daegu
RECRUITING
Cheju Halla General Hospital, Jeju City
RECRUITING
Dong-A University Hospital, Busan
RECRUITING
Pusan National University Hospital, Busan
Lead Sponsor
Chong Kun Dang Pharmaceutical
INDUSTRY